Literature DB >> 23371481

Psoriatic arthritis: phenotypic variance and nosology.

Lihi Eder1, Dafna D Gladman.   

Abstract

Psoriatic arthritis (PsA) has been recognized as a distinct entity different from rheumatoid arthritis. Classification and phenotyping of PsA have progressed substantially since the first classification criteria of the disease were published in 1973 by Moll and Wright. The initial disease patterns described by Moll and Wright have been found to overlap and change over time. There has been controversy about whether these should be maintained or whether the phenotype of PsA should include peripheral and axial disease only. PsA is a multifaceted disease that can present as different clinical phenotypes: peripheral arthritis, axial disease, skin and nail disease, dactylitis, and enthesitis. Development of the high-sensitivity and high-specificity CASPAR criteria was the first step to conducting high-quality trials and observational studies in the field.

Entities:  

Mesh:

Year:  2013        PMID: 23371481     DOI: 10.1007/s11926-013-0316-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  52 in total

1.  High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study.

Authors:  Esperanza Naredo; Ingrid Möller; Eugenio de Miguel; Enrique Batlle-Gualda; Carlos Acebes; Elia Brito; Lucía Mayordomo; Carmen Moragues; Jacqueline Uson; Juan J de Agustín; Agustín Martínez; Eduardo Rejón; Ana Rodriguez; Esteban Daudén
Journal:  Rheumatology (Oxford)       Date:  2011-06-23       Impact factor: 7.580

2.  Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.

Authors:  B Fournié; L Crognier; C Arnaud; L Zabraniecki; V Lascaux-Lefebvre; V Marc; E Ginesty; V Andrieu; C Dromer; A Fournié
Journal:  Rev Rhum Engl Ed       Date:  1999-10

3.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

4.  MR imaging features of foot involvement in patients with psoriasis.

Authors:  C Zuhal Erdem; Nilgun Solak Tekin; Selda Sarikaya; L Oktay Erdem; Sezen Gulec
Journal:  Eur J Radiol       Date:  2007-11-09       Impact factor: 3.528

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

6.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

7.  Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis.

Authors:  D D Gladman; B Brubacher; D Buskila; P Langevitz; V T Farewell
Journal:  Clin Invest Med       Date:  1993-02       Impact factor: 0.825

8.  Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?

Authors:  William J Taylor; Andrew A Harrison
Journal:  Arthritis Rheum       Date:  2004-06-15

9.  On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting.

Authors:  Amit Garg; Dafna D Gladman; Philip J Mease
Journal:  J Rheumatol       Date:  2012-11       Impact factor: 4.666

10.  Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis.

Authors:  Charlotte Wiell; Marcin Szkudlarek; Maria Hasselquist; Jakob M Møller; Aage Vestergaard; Jesper Nørregaard; Lene Terslev; Mikkel Østergaard
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  11 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 2.  Tumor necrosis factor inhibitors in psoriatic arthritis.

Authors:  Santhi Mantravadi; Alexis Ogdie; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2017-05-22       Impact factor: 5.045

Review 3.  Entheseal involvement in systemic disorders.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 2.980

Review 4.  Consensus-based recommendations on the diagnosis, referral and clinical management of patients with psoriatic arthritis.

Authors:  Hanan Al Rayes; Mansour Alazmi; Suzan Attar; Khaled Alderaan; Mushabab Alghamdi; Nayef Alghanim; Ahmed Alhazmi; Nadeer Alkhadhrawi; Mohammad Almohideb; Zeyad Alzahrani; Mohamed Bedaiwi; Hussein Halabi
Journal:  Rheumatol Int       Date:  2021-10-30       Impact factor: 2.631

5.  Time until onset of action when treating psoriatic arthritis: meta-analysis and novel approach of generating confidence intervals.

Authors:  Phuong Anh Pham; Corinna Dressler; Lisa Eisert; Alexander Nast; Ricardo Niklas Werner
Journal:  Rheumatol Int       Date:  2019-01-25       Impact factor: 2.631

Review 6.  [Typical arthritis of the hands : Psoriatic arthritis].

Authors:  Matthias Bollow
Journal:  Radiologe       Date:  2021-03-30       Impact factor: 0.635

7.  Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis.

Authors:  Marzia Dolcino; Claudio Lunardi; Andrea Ottria; Elisa Tinazzi; Giuseppe Patuzzo; Antonio Puccetti
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 8.  Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis.

Authors:  Philip J Mease
Journal:  Rheumatol Ther       Date:  2014-12-09

9.  Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis.

Authors:  Marzia Dolcino; Andrea Ottria; Alessandro Barbieri; Giuseppe Patuzzo; Elisa Tinazzi; Giuseppe Argentino; Ruggero Beri; Claudio Lunardi; Antonio Puccetti
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

10.  Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.

Authors:  Daniel Stekhoven; Almut Scherer; Michael J Nissen; Véronique Grobéty; Nikhil Yawalkar; Peter M Villiger; Burkhard Möller
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.